Intellia Therapeutics Inc buy Canaccord Genuity Group Inc.
Start price
16.06.26
/
50%
€11.80
Target price
16.06.27
€42.31
Performance (%)
6.44%
Price
16.06.26
€12.56
Summary
This prediction is currently active. The BUY prediction by Canaccord_Genuity_Gr shows slight gains of 6.44%. This prediction currently runs until 16.06.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Intellia Therapeutics Inc | 6.44% |
| iShares Core DAX® | 1.163% |
| iShares Nasdaq 100 | 2.585% |
| iShares Nikkei 225® | 7.111% |
| iShares S&P 500 | 1.261% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NTLA) had its "buy" rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $49.00 price target on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€11.66
28.04.26
28.04.26
€49.51
28.04.27
28.04.27
7.72%
16.06.26
16.06.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€11.99
03.03.26
03.03.26
€41.04
03.03.27
03.03.27
4.80%
16.06.26
16.06.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€33.50
13.04.23
13.04.23
€59.72
13.04.24
13.04.24
-29.85%
14.04.24
14.04.24